mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.001 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.002 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |